1. |
孙鑫, 谭婧, 唐立, 等. 重新认识真实世界研究. 中国循证医学杂志, 2017, 17(2): 126-130.
|
2. |
Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis, 1967, 20(8): 637-648.
|
3. |
Roland M, Torgerson DJ. What are pragmatic trials? BMJ, 1998, 316(7127): 285.
|
4. |
Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ, 2008, 337: a2390.
|
5. |
Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ, 2009, 180(10): 47-57.
|
6. |
Loudon K, Treweek S, Sullivan F, et al. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ, 2015, 350: h2147.
|
7. |
Califf RM, Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clin Trials, 2015, 12(5): 436-441.
|
8. |
Taylor D, Carlyle JA, McPherson S, et al. Tavistock Adult Depression Study (TADS): a randomised controlled trial of psychoanalytic psychotherapy for treatment-resistant/treatment-refractory forms of depression. BMC Psychiatry, 2012, 12: 60.
|
9. |
Devereaux PJ, Bhandari M, Clarke M, et al. Need for expertise based randomised controlled trials. BMJ, 2005, 330(7482): 88.
|
10. |
Westendorp WF, Vermeij JD, Zock E, et al. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet, 2015, 385(9977): 1519-1526.
|
11. |
Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new medical research council guidance. Int J Nurs Stud, 2013, 50(5): 587-592.
|